VP/GM, Molecular Diagnostics and Women's Health & Cancer, BD
Speakers
-
Celine Roger-Dalbert
VP, Diagnostic Assays R&D, BD -
Diane Kawa, PhD
Scientific Affairs Director, BD
Event Date & Time
DATE: April 3, 2020
TIME: 9:00am PT, 12:00pm ET
Abstract
The BioGX SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in nasopharyngeal and oropharyngeal swab samples from patients who meet COVID-19 clinical and/or epidemiological criteria. The BioGX SARS-CoV-2 Reagents for BD MAX System is intended for use by trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures and is only for use under the Food and Drug Administration’s Emergency Use Authorization Policy.
Learnings from this webinar will include:
- The assay design for the BioGX SARS-CoV-2 reagents for BD MAX System
- Our commitment to innovation in the molecular space
- Your questions answered
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...